Sekhmet Pharmaventures

Sekhmet Pharmaventures is a Manufacturer/Innovator, CMO/CDMO company operating in the pharmaceutical industry.

Gamot API is the holding company of Sekhmet Pharmaventures Pvt. Ltd. Asian private equity major PAG has formed an investment platform called Gamot API Pte. Ltd. based in Singapore, along with Indian private equity firms, CX Partners and Samara Capital, to buy stakes in fast-growing Indian pharma companies. The Indian subsidiary of Gamot API is known as Sekhmet Pharmaventures Pvt. Ltd. Sekhmet Pharmaventures has acquired major stake in Chennai-based Anjan Drug Pvt. Ltd. in October 2020. Subsequently, Sekhmet Pharmaventures acquired major stake in Optimus Drugs Group of Companies in May 2022.

Company type

Manufacturer/Innovator, CMO/CDMO

Products and services

Custom Manufacturing, Intermediates, Fine and Specialty Chemicals, Pharmaceutical Machinery & Technology

Markets

North America (USA, Canada), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)

Useful Links

Connect with Sekhmet Pharmaventures on LinkedIn

Address

Sekhmet Pharmaventures, 2nd Floor, Sy No. 37/A & 37/P, Plot No.6P, Signature Towers, Kothaguda, Kondapur, Hyderabad, Gujarat, India, 500 084